InvestorsHub Logo
Followers 91
Posts 11351
Boards Moderated 0
Alias Born 06/06/2014

Re: falconer66a post# 326843

Sunday, 08/22/2021 2:15:52 PM

Sunday, August 22, 2021 2:15:52 PM

Post# of 462570
You'll have to explain this:

Me: We don't even know if 3-71 is efficacious in human disease yet.

You: Well, you are welcome to maintain ignorance of the outcomes of blarcamesine dosings in a number of clinical trials.


Do you see how your response logic is flawed? If not, read it again.

Let's look at another one, because it's another stunner. You wrote "Some observers of new drug development rather arbitrarily claim (as in this case) that it is impossible to know if a new drug candidate will actually treat any sort of disease until FDA-approved clinical trials are completed."

No one "rather arbitrarily claims" this. It's in fact true.

Maybe you'll see it if you substituted robust for your "FDA-approved"? Then read your words again:

"It is impossible to know if a new drug candidate will actually treat any sort of disease until robust clinical trials are completed."

Did that help? Still an "arbitrary claim" to you?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News